
Pharmaceuticals in Europe
Description
Pharmaceuticals in Europe
Summary
Pharmaceuticals in Europe industry profile provides top-line qualitative and quantitative summary information including: market size (value 2018-23, and forecast to 2028). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
- The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare. Market values refer to the value generated by market players.
- The European pharmaceuticals market registered revenues of $370.4 billion in 2023, representing a compound annual growth rate (CAGR) of 4.04% between 2018 and 2023.
- Germany captured the largest share of the European pharmaceuticals market in 2023, accounting for a share of 23.5%, followed by France, with a share of 20.3%.
- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the pharmaceuticals market in Europe
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in Europe
- Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the Europe pharmaceuticals market with five year forecasts
- What was the size of the Europe pharmaceuticals market by value in 2023?
- What will be the size of the Europe pharmaceuticals market in 2028?
- What factors are affecting the strength of competition in the Europe pharmaceuticals market?
- How has the market performed over the last five years?
- What are the main segments that make up Europe's pharmaceuticals market?
Table of Contents
46 Pages
- 1 Executive Summary
- 1.1. Market value
- 1.2. Market value forecast
- 1.3. Geography segmentation
- 1.4. Market rivalry
- 1.5. Competitive landscape
- 2 Market Overview
- 2.1. Market definition
- 2.2. Market analysis
- 3 Market Data
- 3.1. Market value
- 4 Market Segmentation
- 4.1. Geography segmentation
- 5 Market Outlook
- 5.1. Market value forecast
- 6 Five Forces Analysis
- 6.1. Summary
- 6.2. Buyer power
- 6.3. Supplier power
- 6.4. New entrants
- 6.5. Threat of substitutes
- 6.6. Degree of rivalry
- 7 Competitive Landscape
- 7.1. Who are the leading players?
- 7.2. What are the strengths of the leading players?
- 7.3. What are the recent developments in the market?
- 8 Company Profiles
- 8.1. AstraZeneca Plc
- 8.2. Sanofi
- 8.3. Roche Holding AG
- 8.4. Novartis AG
- 8.5. GSK plc
- 9 Macroeconomic Indicators
- 9.1. Country data
- 10 Appendix
- 10.1. Methodology
- 10.2. Industry associations
- 10.3. Related MarketLine research
- 10.4. About MarketLine
- List of Tables
- Table 1: Europe pharmaceuticals market value: $ billion, 2018-23
- Table 2: Europe pharmaceuticals market geography segmentation: $ billion, 2023
- Table 3: Europe pharmaceuticals market value forecast: $ billion, 2023-28
- Table 4: AstraZeneca Plc: Key Facts
- Table 5: AstraZeneca Plc: Annual Financial Ratios
- Table 6: AstraZeneca Plc: Key Employees
- Table 7: Sanofi: Key Facts
- Table 8: Sanofi: Annual Financial Ratios
- Table 9: Sanofi: Key Employees
- Table 10: Sanofi: Key Employees Continued
- Table 11: Roche Holding AG: Key Facts
- Table 12: Roche Holding AG: Annual Financial Ratios
- Table 13: Roche Holding AG: Key Employees
- Table 14: Novartis AG: Key Facts
- Table 15: Novartis AG: Annual Financial Ratios
- Table 16: Novartis AG: Key Employees
- Table 17: GSK plc: Key Facts
- Table 18: GSK plc: Annual Financial Ratios
- Table 19: GSK plc: Key Employees
- Table 20: Europe Size of Population (million), 2019-23
- Table 21: Europe Real GDP (constant 2010 prices, $ billion), 2019-23
- Table 22: Europe GDP (current prices, $ billion), 2019-23
- Table 23: Europe Inflation, 2019-23
- Table 24: Europe Consumer Price Index (absolute), 2019-23
- Table 25: Europe Exchange Rate, 2018-23
- List of Figures
- Figure 1: 220 Laboratories Inc: Deal Activity by Deal Type - Volume (2020 - YTD*2024)
- Figure 2: 220 Laboratories Inc: Private Equity and Ownership Volume and Value Trend (2020 - YTD*2024)
- Figure 3: 220 Laboratories Inc: Private Equity and Ownership Volume by Deal Type (2020 - YTD*2024)
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.